Adverum Biotechnologies - 53 Year Dividend History | ADVM

Historical dividend payout and yield for Adverum Biotechnologies (ADVM) since 1971. The current TTM dividend payout for Adverum Biotechnologies (ADVM) as of April 19, 2024 is $0.00. The current dividend yield for Adverum Biotechnologies as of April 19, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.231B $0.004B
Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Adverum develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Adverum?s core capabilities include clinical development, novel vector discovery and in-house manufacturing expertise, specifically in scalable process development, assay development, and current Good Manufacturing Practices quality control.
Stock Name Country Market Cap PE Ratio